Characterization of a prolactin gene polymorphism and its associations with systemic lupus erythematosus

Adam Stevens, David Ray, Aliya Alansari, Ali Hajeer, Wendy Thomson, Rachelle Donn, William E.R. Ollier, Jane Worthington, Julian R.E. Davis

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

Objective. Hyperprolactinemia is associated with systemic lupus erythematosus (SLE), but the mechanism is unknown. Prolactin is expressed in T lymphocytes and is under the control of an alternative promoter region. We characterized a G/T single-nucleotide polymorphism (SNP) at position -1149 of this promoter and assessed its prevalence in patients with SLE. Methods. Electrophoretic mobility shift assays (EMSAs) were performed to determine DNA protein complex formation in the prolactin promoter. Transient transfection of reporter gene constructs containing the G/T promoter alleles into the Jurkat T cell line were used to determine transcription activity. Peripheral blood lymphocytes (PBLs) were treated in vitro with phytohemagglutinin (PHA) to determine levels of prolactin messenger RNA (mRNA). Results. EMSAs indicated that binding of a GATA-related transcription factor was altered by the G/T SNP at position -1149. Transient transfection studies in Jurkat cells showed that the G allele consistently produced higher promoter activity. PHA treatment of PBLs in vitro induced a greater increment of prolactin mRNA from patients with the GG-1149 genotype than from those with the TT-1149 genotype. Disease association studies in a cohort of SLE patients demonstrated an increased frequency of the prolactin -1149 G allele compared with control subjects. Conclusion. We found a functionally significant polymorphism that alters prolactin promoter activity and mRNA levels in the lymphocytes. Altered local prolactin production by immune cells may contribute to disease progression by affecting T cell function.

Original languageEnglish
Pages (from-to)2358-2366
Number of pages9
JournalArthritis and Rheumatism
Volume44
Issue number10
DOIs
Publication statusPublished - 2001

Fingerprint

Systemic Lupus Erythematosus
Prolactin
Genes
Jurkat Cells
Alleles
Phytohemagglutinins
Electrophoretic Mobility Shift Assay
Lymphocytes
T-Lymphocytes
Messenger RNA
Single Nucleotide Polymorphism
Transfection
Genotype
GATA Transcription Factors
Hyperprolactinemia
Reporter Genes
Genetic Promoter Regions
Disease Progression
Cell Line
DNA

ASJC Scopus subject areas

  • Immunology and Allergy
  • Rheumatology
  • Immunology
  • Pharmacology (medical)

Cite this

Characterization of a prolactin gene polymorphism and its associations with systemic lupus erythematosus. / Stevens, Adam; Ray, David; Alansari, Aliya; Hajeer, Ali; Thomson, Wendy; Donn, Rachelle; Ollier, William E.R.; Worthington, Jane; Davis, Julian R.E.

In: Arthritis and Rheumatism, Vol. 44, No. 10, 2001, p. 2358-2366.

Research output: Contribution to journalArticle

Stevens, Adam ; Ray, David ; Alansari, Aliya ; Hajeer, Ali ; Thomson, Wendy ; Donn, Rachelle ; Ollier, William E.R. ; Worthington, Jane ; Davis, Julian R.E. / Characterization of a prolactin gene polymorphism and its associations with systemic lupus erythematosus. In: Arthritis and Rheumatism. 2001 ; Vol. 44, No. 10. pp. 2358-2366.
@article{6a0d645900ff4ae2a3b78bd020fe721a,
title = "Characterization of a prolactin gene polymorphism and its associations with systemic lupus erythematosus",
abstract = "Objective. Hyperprolactinemia is associated with systemic lupus erythematosus (SLE), but the mechanism is unknown. Prolactin is expressed in T lymphocytes and is under the control of an alternative promoter region. We characterized a G/T single-nucleotide polymorphism (SNP) at position -1149 of this promoter and assessed its prevalence in patients with SLE. Methods. Electrophoretic mobility shift assays (EMSAs) were performed to determine DNA protein complex formation in the prolactin promoter. Transient transfection of reporter gene constructs containing the G/T promoter alleles into the Jurkat T cell line were used to determine transcription activity. Peripheral blood lymphocytes (PBLs) were treated in vitro with phytohemagglutinin (PHA) to determine levels of prolactin messenger RNA (mRNA). Results. EMSAs indicated that binding of a GATA-related transcription factor was altered by the G/T SNP at position -1149. Transient transfection studies in Jurkat cells showed that the G allele consistently produced higher promoter activity. PHA treatment of PBLs in vitro induced a greater increment of prolactin mRNA from patients with the GG-1149 genotype than from those with the TT-1149 genotype. Disease association studies in a cohort of SLE patients demonstrated an increased frequency of the prolactin -1149 G allele compared with control subjects. Conclusion. We found a functionally significant polymorphism that alters prolactin promoter activity and mRNA levels in the lymphocytes. Altered local prolactin production by immune cells may contribute to disease progression by affecting T cell function.",
author = "Adam Stevens and David Ray and Aliya Alansari and Ali Hajeer and Wendy Thomson and Rachelle Donn and Ollier, {William E.R.} and Jane Worthington and Davis, {Julian R.E.}",
year = "2001",
doi = "10.1002/1529-0131(200110)44:10<2358::AID-ART399>3.0.CO;2-K",
language = "English",
volume = "44",
pages = "2358--2366",
journal = "Arthritis and Rheumatology",
issn = "2326-5191",
publisher = "John Wiley and Sons Ltd",
number = "10",

}

TY - JOUR

T1 - Characterization of a prolactin gene polymorphism and its associations with systemic lupus erythematosus

AU - Stevens, Adam

AU - Ray, David

AU - Alansari, Aliya

AU - Hajeer, Ali

AU - Thomson, Wendy

AU - Donn, Rachelle

AU - Ollier, William E.R.

AU - Worthington, Jane

AU - Davis, Julian R.E.

PY - 2001

Y1 - 2001

N2 - Objective. Hyperprolactinemia is associated with systemic lupus erythematosus (SLE), but the mechanism is unknown. Prolactin is expressed in T lymphocytes and is under the control of an alternative promoter region. We characterized a G/T single-nucleotide polymorphism (SNP) at position -1149 of this promoter and assessed its prevalence in patients with SLE. Methods. Electrophoretic mobility shift assays (EMSAs) were performed to determine DNA protein complex formation in the prolactin promoter. Transient transfection of reporter gene constructs containing the G/T promoter alleles into the Jurkat T cell line were used to determine transcription activity. Peripheral blood lymphocytes (PBLs) were treated in vitro with phytohemagglutinin (PHA) to determine levels of prolactin messenger RNA (mRNA). Results. EMSAs indicated that binding of a GATA-related transcription factor was altered by the G/T SNP at position -1149. Transient transfection studies in Jurkat cells showed that the G allele consistently produced higher promoter activity. PHA treatment of PBLs in vitro induced a greater increment of prolactin mRNA from patients with the GG-1149 genotype than from those with the TT-1149 genotype. Disease association studies in a cohort of SLE patients demonstrated an increased frequency of the prolactin -1149 G allele compared with control subjects. Conclusion. We found a functionally significant polymorphism that alters prolactin promoter activity and mRNA levels in the lymphocytes. Altered local prolactin production by immune cells may contribute to disease progression by affecting T cell function.

AB - Objective. Hyperprolactinemia is associated with systemic lupus erythematosus (SLE), but the mechanism is unknown. Prolactin is expressed in T lymphocytes and is under the control of an alternative promoter region. We characterized a G/T single-nucleotide polymorphism (SNP) at position -1149 of this promoter and assessed its prevalence in patients with SLE. Methods. Electrophoretic mobility shift assays (EMSAs) were performed to determine DNA protein complex formation in the prolactin promoter. Transient transfection of reporter gene constructs containing the G/T promoter alleles into the Jurkat T cell line were used to determine transcription activity. Peripheral blood lymphocytes (PBLs) were treated in vitro with phytohemagglutinin (PHA) to determine levels of prolactin messenger RNA (mRNA). Results. EMSAs indicated that binding of a GATA-related transcription factor was altered by the G/T SNP at position -1149. Transient transfection studies in Jurkat cells showed that the G allele consistently produced higher promoter activity. PHA treatment of PBLs in vitro induced a greater increment of prolactin mRNA from patients with the GG-1149 genotype than from those with the TT-1149 genotype. Disease association studies in a cohort of SLE patients demonstrated an increased frequency of the prolactin -1149 G allele compared with control subjects. Conclusion. We found a functionally significant polymorphism that alters prolactin promoter activity and mRNA levels in the lymphocytes. Altered local prolactin production by immune cells may contribute to disease progression by affecting T cell function.

UR - http://www.scopus.com/inward/record.url?scp=0034767960&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034767960&partnerID=8YFLogxK

U2 - 10.1002/1529-0131(200110)44:10<2358::AID-ART399>3.0.CO;2-K

DO - 10.1002/1529-0131(200110)44:10<2358::AID-ART399>3.0.CO;2-K

M3 - Article

VL - 44

SP - 2358

EP - 2366

JO - Arthritis and Rheumatology

JF - Arthritis and Rheumatology

SN - 2326-5191

IS - 10

ER -